Innovative use of contegra valved conduit in left iliocaval stent thrombosis
- PMID: 33060901
- PMCID: PMC7525597
- DOI: 10.1007/s12055-017-0593-z
Innovative use of contegra valved conduit in left iliocaval stent thrombosis
Abstract
Thrombosis of an iliofemoral vein accounts for 25% of all lower extremity deep vein thrombosis (DVT) and is associated with an increased risk of pulmonary embolism (PE), limb malperfusion, and post-thrombotic syndrome (PTS). Endothelial injury, hypercoagulability and stasis constitute Virchow's triad of thrombogenesis. Common predisposing conditions include the postoperative state, prolonged immobility (e.g., travel, hospitalization), malignancy, pregnancy, and inherited hypercoagulable conditions. Long-term complications of DVT include persistent lower extremity edema, venous claudication, hyperpigmentation, and ulceration-collectively called as PTS and are associated with a reduced quality of life with increased health care expenses. The indications for open surgical revascularization are rare and usually reserved for patients whose symptoms are refractory to anticoagulation and endovascular treatment. Here, we report a successful decompression of severe venous edema of left lower limb post left iliocaval stent thrombosis in a 50-year-old female patient. We used two contegra valved conduits which were sutured end to end with each other in the same direction as a bypass graft. Proximal end of the conduit was anastomosed to left common femoral vein and the distal end to the distal inferior vena cava (IVC). It provided prompt and effective venous outflow with complete resolution of the venous edema of left lower limb. computed tomography (CT) venogram done after 3 months of surgery showed patent contegra valved conduit with thrombosed iliocaval stent.
Keywords: Contegra valved conduit; PE-Pulmonary embolism; PTS-Post thrombotic syndrome.
© Indian Association of Cardiovascular-Thoracic Surgeons 2017.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures



Similar articles
-
The incidence of contralateral iliac venous thrombosis after stenting across the iliocaval confluence in patients with acute or chronic venous outflow obstruction.J Vasc Surg Venous Lymphat Disord. 2014 Jul;2(3):253-9. doi: 10.1016/j.jvsv.2013.12.007. Epub 2014 Feb 7. J Vasc Surg Venous Lymphat Disord. 2014. PMID: 26993383
-
Factors Associated with Contralateral Deep Venous Thrombosis after Iliocaval Venous Stenting.Eur J Vasc Endovasc Surg. 2017 Dec;54(6):745-751. doi: 10.1016/j.ejvs.2017.07.011. Epub 2017 Sep 5. Eur J Vasc Endovasc Surg. 2017. PMID: 28886989
-
Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.J Vasc Surg Venous Lymphat Disord. 2019 Mar;7(2):153-161. doi: 10.1016/j.jvsv.2018.08.014. Epub 2019 Jan 16. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30660580
-
Update on diagnosis and treatment strategies in patients with post-thrombotic syndrome due to chronic venous obstruction and role of endovenous recanalization.J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):592-600. doi: 10.1016/j.jvsv.2019.01.062. Epub 2019 May 5. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31068275 Review.
-
Iliocaval complications of retroperitoneal fibrosis.Am J Surg. 1994 Aug;168(2):179-83. doi: 10.1016/s0002-9610(94)80063-4. Am J Surg. 1994. PMID: 8053522 Review.
References
-
- Plate G, Hollier LH, Gloviczki P, Dewanjee MK, Kaye MP. Overcoming failure of venous vascular prosthesis. Surg. 1984;96:503–510. - PubMed
Publication types
LinkOut - more resources
Full Text Sources